Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33


Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma.

Sampson JH, Aldape KD, Archer GE, Coan A, Desjardins A, Friedman AH, Friedman HS, Gilbert MR, Herndon JE, McLendon RE, Mitchell DA, Reardon DA, Sawaya R, Schmittling R, Shi W, Vredenburgh JJ, Bigner DD, Heimberger AB.

Neuro Oncol. 2011 Mar;13(3):324-33. doi: 10.1093/neuonc/noq157. Epub 2010 Dec 10.


Coordination of intratumoral immune reaction and human colorectal cancer recurrence.

Camus M, Tosolini M, Mlecnik B, Pagès F, Kirilovsky A, Berger A, Costes A, Bindea G, Charoentong P, Bruneval P, Trajanoski Z, Fridman WH, Galon J.

Cancer Res. 2009 Mar 15;69(6):2685-93. doi: 10.1158/0008-5472.CAN-08-2654. Epub 2009 Mar 3.


Prediction of survival using absolute lymphocyte count for newly diagnosed patients with multiple myeloma: a retrospective study.

Ege H, Gertz MA, Markovic SN, Lacy MQ, Dispenzieri A, Hayman SR, Kumar SK, Porrata LF.

Br J Haematol. 2008 Jun;141(6):792-8. doi: 10.1111/j.1365-2141.2008.07123.x. Epub 2008 Apr 10.


The epidemiology of glucocorticoid-associated adverse events.

McDonough AK, Curtis JR, Saag KG.

Curr Opin Rheumatol. 2008 Mar;20(2):131-7. doi: 10.1097/BOR.0b013e3282f51031. Review.


Absolute lymphocyte count is a novel prognostic indicator in ALL and AML: implications for risk stratification and future studies.

De Angulo G, Yuen C, Palla SL, Anderson PM, Zweidler-McKay PA.

Cancer. 2008 Jan 15;112(2):407-15.


Absolute lymphocyte count predicts therapeutic efficacy and survival at the time of radioimmunotherapy in patients with relapsed follicular lymphomas.

Porrata LF, Ristow K, Witzig TE, Tuinistra N, Habermann TM, Inwards DJ, Ansell SM, Micallef IN, Johnston PB, Markovic SN.

Leukemia. 2007 Dec;21(12):2554-6. Epub 2007 Jun 21. No abstract available.


Risk and predictors of infection leading to hospitalisation in a large primary-care-derived cohort of patients with inflammatory polyarthritis.

Franklin J, Lunt M, Bunn D, Symmons D, Silman A.

Ann Rheum Dis. 2007 Mar;66(3):308-12. Epub 2006 Sep 19.


Absolute lymphocyte count predicts overall survival in follicular lymphomas.

Siddiqui M, Ristow K, Markovic SN, Witzig TE, Habermann TM, Colgan JP, Inwards DJ, White WL, Ansell SM, Micallef IN, Johnston PB, Call TG, Porrata LF.

Br J Haematol. 2006 Sep;134(6):596-601. Epub 2006 Aug 1.


Population-based assessment of adverse events associated with long-term glucocorticoid use.

Curtis JR, Westfall AO, Allison J, Bijlsma JW, Freeman A, George V, Kovac SH, Spettell CM, Saag KG.

Arthritis Rheum. 2006 Jun 15;55(3):420-6.


Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry.

Lichtenstein GR, Feagan BG, Cohen RD, Salzberg BA, Diamond RH, Chen DM, Pritchard ML, Sandborn WJ.

Clin Gastroenterol Hepatol. 2006 May;4(5):621-30. Erratum in: Clin Gastroenterol Hepatol. 2006 Jul;4(7):931.


Early lymphocyte recovery after autologous stem cell transplantation predicts superior survival in mantle-cell lymphoma.

Joao C, Porrata LF, Inwards DJ, Ansell SM, Micallef IN, Johnston PB, Gastineau DA, Markovic SN.

Bone Marrow Transplant. 2006 May;37(9):865-71.


Effector memory T cells, early metastasis, and survival in colorectal cancer.

Pagès F, Berger A, Camus M, Sanchez-Cabo F, Costes A, Molidor R, Mlecnik B, Kirilovsky A, Nilsson M, Damotte D, Meatchi T, Bruneval P, Cugnenc PH, Trajanoski Z, Fridman WH, Galon J.

N Engl J Med. 2005 Dec 22;353(25):2654-66.


Absolute lymphocyte count recovery after induction chemotherapy predicts superior survival in acute myelogenous leukemia.

Behl D, Porrata LF, Markovic SN, Letendre L, Pruthi RK, Hook CC, Tefferi A, Elliot MA, Kaufmann SH, Mesa RA, Litzow MR.

Leukemia. 2006 Jan;20(1):29-34.


Primary brain tumors treated with steroids and radiotherapy: low CD4 counts and risk of infection.

Hughes MA, Parisi M, Grossman S, Kleinberg L.

Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1423-6.


Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group.

N Engl J Med. 2005 Mar 10;352(10):987-96.


Efficacy of cancer chemotherapy in relation to the pretreatment number of lymphocytes in patients with metastatic solid tumors.

Lissoni P, Brivio F, Fumagalli L, Messina G, Ghezzi V, Frontini L, Giani L, Vaghi M, Ardizzoia A, Gardani GS.

Int J Biol Markers. 2004 Apr-Jun;19(2):135-40.


Selective CD4+ lymphopenia in melanoma patients treated with temozolomide: a toxicity with therapeutic implications.

Su YB, Sohn S, Krown SE, Livingston PO, Wolchok JD, Quinn C, Williams L, Foster T, Sepkowitz KA, Chapman PB.

J Clin Oncol. 2004 Feb 15;22(4):610-6. Epub 2004 Jan 15. Erratum in: J Clin Oncol. 2004 May 15;22(10):2038.


Pneumocystis carinii pneumonia in HIV negative patients with primary brain tumors.

Mahindra AK, Grossman SA.

J Neurooncol. 2003 Jul;63(3):263-70.


Correlation of early lymphocyte recovery and progression-free survival after autologous stem-cell transplant in patients with Hodgkin's and non-Hodgkin's Lymphoma.

Gordan LN, Sugrue MW, Lynch JW, Williams KD, Khan SA, Moreb JS.

Bone Marrow Transplant. 2003 Jun;31(11):1009-13.


Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer.

Zhang L, Conejo-Garcia JR, Katsaros D, Gimotty PA, Massobrio M, Regnani G, Makrigiannakis A, Gray H, Schlienger K, Liebman MN, Rubin SC, Coukos G.

N Engl J Med. 2003 Jan 16;348(3):203-13.

Supplemental Content

Support Center